Everything you need to know about Continuous glucose monitoring CGM

Everything you need to know about Continuous glucose monitoring CGM by Dr. Om J Lakhani
In this video, Dr. Om J Lakhani provides an in-depth explanation of continuous glucose monitoring (CGM). He starts by explaining CGM and how it's different from CGMS, a trademarked term (00:00). He details the difference between CGM and SMBG (Self-monitoring of blood glucose), with the former being a continuous monitoring system that provides a continuous snapshot of glucose levels, while the latter only provides snapshots at specific points in time (00:57). The doctor then further differentiates the three types of CGMs - professional CGM, flash CGM, and real-time CGM, and how they work in practical terms (03:44). He subsequently explains the difference in glucose measurements from different mediums such as venous blood glucose, capillary blood glucose, and interstitial fluid glucose (05:47). Dr. Lakhani then introduces the concepts of 'time in range', 'time above range', and 'time below range' and their relevance to diabetes management (09:20). In addition, he explains how to interpret a CGM report and what constitutes a good report (12:55). Finally, he discusses how time in range correlates with HBA1c levels and why it is important for diabetes management (16:06).
In this segment of the video, Dr. Om J Lakhani continues his comprehensive explanation of Continuous Glucose Monitoring (CGM). He discusses the correlation between 'time in range' and diabetes-related complications. He emphasizes how an increase in time in range reduces the risk of these complications significantly (20:04). He encourages healthcare professionals to aim for a 'time in range' of 70% or more (20:57). As he continues, he predicts that the use of 'time in range' over HbA1c as a measure of diabetic control will become more common in the future, due to its better reflection of patient satisfaction and quality of life (21:14). He talks about the limitations of HbA1c measurements, especially in patients with chronic kidney disease and hemoglobinopathies, and praises 'time in range' for its comprehensive reflection of glucose control (22:10). Dr. Lakhani concludes the section by discussing how 'time in range' measurements can help guide the use of insulin and aid in the management of gestational diabetes (23:21). He then goes on to discuss 'glycemic variability' and its importance in understanding glucose control in patients (25:12).

[@manusharma9093]

Thanks Sir

[@matiullahkhan9111]

Great teacher Dr Om Lakani 👍
All your videos are Impressive
Dr Matiullah Khan
Consultant Endocrinologist
Pakistan

[@EndocrinologyIndia]

Thank you